Should a patient with a brain tumor receive anticoagulation for a thromboembolic event?

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]

Alejandro Morales, MD
Department of General Internal Medicine, Cleveland Clinic

David J. Adelstein, MD
Department of Hematology and Medical Oncology, Cleveland Clinic

Address: David J. Adelstein, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail [email protected]